BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 205805)

  • 1. [Etiology and pathogenesis of arteriosclerosis].
    Schettler G; Mörl H
    Naturwissenschaften; 1978 Mar; 65(3):130-6. PubMed ID: 205805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease.
    Salel AF; Riggs K; Mason DT; Amsterdam EA; Zelis R
    Am J Med; 1974 Dec; 57(6):897-903. PubMed ID: 4378395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipids and arteriosclerosis].
    Carmena R
    Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of arteriosclerosis. Current basis].
    Epstein FH; Gutzwiller F; Howald H; Junod B; Schweizer W
    Schweiz Med Wochenschr; 1979 Aug; 109(32):1171-80. PubMed ID: 227049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of arteriosclerosis].
    Emmrich R
    Z Gesamte Inn Med; 1968 Jan; 23(2):28-32. PubMed ID: 4177784
    [No Abstract]   [Full Text] [Related]  

  • 6. Biology of cholesterol, lipoproteins and atherosclerosis.
    Havel RJ
    Clin Exp Hypertens A; 1989; 11(5-6):887-900. PubMed ID: 2676261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperlipoproteinemia and its role in the pathogenesis of arteriosclerosis].
    Klimov AN
    Patol Fiziol Eksp Ter; 1972; 16(5):3-12. PubMed ID: 4363573
    [No Abstract]   [Full Text] [Related]  

  • 8. [Causes and prevention of arteriosclerosis].
    Carlier J; Mbuyamba P; Lisin N; Andriange M
    Rev Med Liege; 1973 Sep; 28(19):621-30. PubMed ID: 4751552
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiology of atherosclerosis: an updated overview.
    Criqui MH
    Am J Cardiol; 1986 Feb; 57(5):18C-23C. PubMed ID: 3511663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietary aspects of hyperlipidemia.
    Gotto AM; Scott L
    J Am Diet Assoc; 1973 Jun; 62(6):617-25. PubMed ID: 4350194
    [No Abstract]   [Full Text] [Related]  

  • 12. High-density lipoprotein and atheroma.
    Lancet; 1978 Dec; 2(8103):1291-2. PubMed ID: 82791
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension, blood lipids, and cigarette smoking as co-risk factors for coronary heart disease.
    Kannel WB
    Ann N Y Acad Sci; 1978 Mar; 304():128-39. PubMed ID: 212996
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of miRNAs in cardiovascular disease risk factors.
    Jones Buie JN; Goodwin AJ; Cook JA; Halushka PV; Fan H
    Atherosclerosis; 2016 Nov; 254():271-281. PubMed ID: 27693002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk and prophylaxis in coronary disease].
    Szczeklik E
    Przegl Lek; 1973; 30(4):353-8. PubMed ID: 4711356
    [No Abstract]   [Full Text] [Related]  

  • 18. Cigarette smoke and lipoprotein modification. A possible interpretation for development of atherosclerosis.
    Yokode M; Nagano Y; Arai H; Ueyama K; Ueda Y; Kita T
    Ann N Y Acad Sci; 1995 Jan; 748():294-300. PubMed ID: 7695173
    [No Abstract]   [Full Text] [Related]  

  • 19. [An imperative when faced by arteriosclerosis: the need to combat all and every risk factor (hypertension, smoking, hyperlipidemia, sedentary life, stress)].
    Dallocchio M; Clementy J; Bricaud H
    Sem Hop Ther; 1974 Dec; 50(10):687-90. PubMed ID: 4465919
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of risk factors in the development of atherosclerosis.
    Frohlich J; Dobiasova M; Lear S; Lee KW
    Crit Rev Clin Lab Sci; 2001 Oct; 38(5):401-40. PubMed ID: 11720280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.